GCP
OPTN

GSA Capital Partners’s OptiNose OPTN Stock Holding History

GSA Capital Partners’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,072
Closed -$61K – 1914
2024
Q3 		$61K Buy
+6,072
New +$88.5K ﹤0.01% 1514
2024
Q2 		– Sell
-5,067
Closed -$111K – 1928
2024
Q1 		$111K Buy
5,067
+3,445
+212% +$76.5K 0.01% 1481
2023
Q4 		$31K Buy
+1,622
New +$29.6K ﹤0.01% 1431
2021
Q4 		– Sell
-35,163
Closed -$1.58M – 1685
2021
Q3 		$1.58M Buy
35,163
+11,337
+48% +$476K 0.16% 114
2021
Q2 		$1.11M Buy
23,826
+16,236
+214% +$829K 0.13% 209
2021
Q1 		$420K Buy
+7,590
New +$462K 0.07% 444
2020
Q2 		– Sell
-2,248
Closed -$151K – 967
2020
Q1 		$151K Buy
+2,248
New +$226K 0.04% 830

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

GSA Capital Partners's OPTN Position: Q4 2024 in Review

GSA Capital Partners sold out of OptiNose (OPTN) in Q4 2024, closing a stake of 6,072 shares — an estimated $61K sold.

GSA Capital Partners first reported a position in OPTN in Q1 2020 and held it in 7 quarters. The position peaked at $1.58M in Q3 2021. 40 funds tracked by Wall St. Rank hold OPTN as of Q4 2024.

  • GSA Capital Partners reported no remaining OptiNose position as of Q4 2024 after selling out during the quarter.
  • GSA Capital Partners sold 6,072 OptiNose shares in Q4 2024, an estimated $61K.
  • GSA Capital Partners first reported a position in OptiNose in Q1 2020 and held it in 7 quarters.
  • GSA Capital Partners's OptiNose position peaked at $1.58M in Q3 2021.
  • 40 funds tracked by Wall St. Rank held OptiNose as of Q4 2024.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.